Elsevier

Human Pathology

Volume 30, Issue 1, January 1999, Pages 72-77
Human Pathology

Original contribution
Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: Role of the sydney system

https://doi.org/10.1016/S0046-8177(99)90303-9Get rights and content

Abstract

Pathologists are frequently asked to evaluate gastric mucosal biopsy specimens for the presence of Helicobacter pylori infection and for potentially important changes such as intestinal metaplasia. No agreed-on system is both available and prospectively shown to provide reliable estimates of the underlying pathological condition. The Sydney System combined topographical, morphological, and causative information for evaluation of gastric biopsy specimens and provided recommendations regarding biopsy site and number. Both the biopsy sites and number were changed in 1994. Gastric biopsy specimens from patients who had multiple biopsies performed on predetermined sites were examined to compare the original and the revised Sydney Systems for the detection of intestinal metaplasia and H pylori. The diagnosis based on both versions of the Sydney System was then compared with that obtained by evaluating all specimens. Forty-six patients were studied, 20 with H pylori infection and 36 with intestinal metaplasia. Using either version of the Sydney System correctly categorized H pylori infection status in 100%. Both the original and the revised Sydney recommendations seriously underestimated the prevalence of intestinal metaplasia. Intestinal metaplasia was missed in more than 50% of those with confirmed intestinal metaplasia. No set or site of biopsy specimens was found that could reliably exclude the presence of intestinal metaplasia. Current and future studies that use the Sydney System as basis for detecting intestinal metaplasia are not likely to be reliable. Likewise, using the Sydney System to test posttherapy or with time will not accurately reflect the true status of intestinal metaplasia.

References (39)

  • A Di Napoli et al.

    Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori

    J Clin Pathol

    (1992)
  • JI Wyatt et al.

    Helicobacter pylori, gastritis, and peptic ulceration in the elderly

    J Clin Pathol

    (1992)
  • PJ Hu et al.

    Oxyntic and antral gastritis in the People's Republic of China: Diagnosis and relationship to Helicobacter pylori

    Am J Gastroenterol

    (1992)
  • G Battaglia et al.

    Helicobacter pylori infection, cigarette smoking and alcohol consumption: A histological and clinical study on 286 subjects

    Ital J Gastroenterol

    (1993)
  • P Correa

    A human model of gastric carcinogenesis

    Cancer Res

    (1988)
  • P Correa

    Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention

    Cancer Res

    (1992)
  • S Recavarren Arce et al.

    Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer

    Scand J Gastroenterol

    (1991)
  • P Sipponen

    Gastric cancer: A long-term consequence of Helicobacter pylori infection?

    Scand J Gastroenterol

    (1994)
  • P Sipponen et al.

    Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma: Comparison with a representative population sample

    Cancer

    (1983)
  • Cited by (129)

    • Gastritis: The clinico-pathological spectrum

      2021, Digestive and Liver Disease
    • Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations

      2020, Gastroenterology
      Citation Excerpt :

      Additionally, the decision to obtain gastric biopsies was not standardized. The other major limitation is that many of the studies did not report the biopsy protocol and/or did not obtain biopsies according to the updated Sydney system.19,20 In addition to the 53 studies that reported the prevalence of GIM, we also identified 6 studies that reported the prevalence of GIM in H pylori–exposed subjects and 1 study that reported the prevalence of GIM in first-degree relatives of patients with gastric cancer.21–27

    • Tissue Sampling, Specimen Handling, and Laboratory Processing

      2019, Clinical Gastrointestinal Endoscopy
    View all citing articles on Scopus

    Supported by the Department of Veterans Affairs and by NIH grants DK53659 and CA67469, as well as the generous support of Hilda Schwartz.

    View full text